Status:
WITHDRAWN
Impact of Relaxing Visual Immersion on Anxiety During Anti-cancer Treatment.
Lead Sponsor:
Elsan
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Since the 60's and 70's, the soar of audiovisual technologies allowed the development of virtual reality (VR). These technologies were then adapted to help reducing anxiety and pain during medical pro...
Detailed Description
The diagnosis of cancer and the treatments used may be the cause, for the patient, of a significant emotional and psychological anxiety. For many years, several studies have evaluated the impact of vi...
Eligibility Criteria
Inclusion
- Male or female aged 18 and over.
- Patient with cancer (any location) who need to receive an intravenous (IV) cancer treatment (adjuvant, neoadjuvant or palliative) when taking initial disease burden or upon relapse (the IV treatments concomitant with radiotherapy are also possible).
- Patients scheduled for at least 3 consecutive sessions of IV anti-cancer treatment.
- Patient under health insurance plan.
- Information and signature of informed consent by the patient to participate in the study.
Exclusion
- Pregnant women.
- Vulnerable patient (psychiatric illness, detainee, under legal protection, emancipated child).
Key Trial Info
Start Date :
September 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04528238
Start Date
September 1 2022
End Date
September 1 2024
Last Update
October 27 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.